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Abstract The mean global prevalence of tension-type
headache (TTH) in adult is 42 %. To date, there have been
no Italian studies on TTH prevalence in the adult general
population. Therefore, we conducted a cross-sectional
study, called PACE, aimed at detecting the prevalence of
primary headaches in the city of Parma’s adult general
population. 904 subjects representative of Parma’s adult
general population were interviewed face to face by a
physician of our Headache Centre. Crude past-year preva-
lence for definite TTH was 19.4 % (95 % CI 16.8–21.9;
18.4 %, 95 % CI 14.6–22.3 in men, and 20.1 %, 95 % CI
16.6–23.6 in women), namely, 9.0 % (95 % CI 7.1–10.8)
for infrequent TTH, 9.8 % (95 % CI 7.9–11.8) for frequent
TTH, and 0.6 % (95 % CI 0.1–1) for chronic TTH. Crude
prevalence for probable TTH was 2.3 % (95 % CI 1.3–3.3;
2 %, 95 % CI 0.6–3.4 in men, and 2.6 %, 95 % CI 1.2–3.9
in women). Our results indicate a TTH prevalence (19.4 %)
at the lower limit of data ranges for Western countries, and
prevalence rates for infrequent forms (9 %) do not appear
different from those of frequent forms (9.8 %).
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Introduction
Primary headaches represent a problem for public health
systems because they have a high prevalence, are spread all
over the world and are associated with a lot of medical
comorbidities [1, 2]. Many studies have been conducted
worldwide to determine migraine prevalence [3], while
there have been few studies on tension-type headache
(TTH), the majority of these are from Europe.
TTH has a mean global prevalence of 42 % [3], but
figures all over the world differ widely. No Italian studies
on TTH prevalence in the general population aged 18 years
or over have been available after the publication of the IHS
diagnostic criteria [6]. Prencipe et al. [7] found a TTH
prevalence rate of 44.5 % among 833 Italians aged 65 or
over living in three rural villages near L’Aquila, a city in
the Abruzzo region of central Italy. Prevalence rates were
significantly higher in women (55.1 %) than in men
(30.9 %; F:M ratio = 2.4), and a significant inverse asso-
ciation between TTH prevalence and advancing age was
found.
The PACE study is a cross-sectional study aimed at
detecting the prevalence and clinical features of primary
headaches in the city of Parma’s adult general population:
we report data about the past-year prevalence of TTH and
its subtypes.
Materials and methods
Our survey was conducted between September 2007 and
February 2009 in Parma, a city in the Emilia-Romagna
region of Northern Italy. As of 31 December 2006
(Table 1), the city had 152,140 inhabitants aged C18 years
(71,280 men and 80,860 women). The official census of
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Parma residents as of 31 December 2006 was provided by
the Parma Municipal Statistics Office [8].
Sampling
Our initial study sample consisted of all residents regis-
tered with a general practitioner (GP) in downtown Parma.
Electronic patient records for the GP practice (as of 1
January 2007) were officially provided by the Parma local
health care unit of Italy’s National Health Service (NHS).
Our study population can be considered representative
of the Italian adult general population, because in Italy
primary care must be provided by a physician free of
charge to each citizen from birth. Italy’s NHS keeps offi-
cial records of patients in the practice of each primary care
provider. For primary care providers to best fulfill their
role, patients must be free to make their choice with no
geographic, administrative, or economic constraints. Our
choice of the initial study sample was influenced by the
number of patients in the GP’s practice (n = 1,300), as
well as by the successful results of past cooperations with
our team [9]. We removed all subjects aged \18 years
from the list. Our initial study sample consisted of 1,270
subjects, 681 women and 589 men.
Interview and case definition
The interview was conducted face to face by one of the
physicians of the Parma Headache Centre and consisted in
the administration of a specially designed, previously val-
idated 13-section questionnaire for the diagnosis of pri-
mary headaches in the general population [10]. A
neurological examination was made except for subjects
unable to reach the appointment venue, that were inter-
viewed by phone. The questionnaire included a screening
question ‘‘Have you had headache in the last year?’’ that
made it possible to detect subjects with past-year headache.
Through questions in the section about headache, it was
possible to diagnose the primary headache types that each
subject was suffering from. The diagnosis was based on the
ICHD-II criteria [11]. The questionnaire versus the clinical
interview showed an excellent concordance rate
(K value = 0.96, 95 % CI 0.88–1) for the first diagnosis
and a good concordance rate for the second diagnosis
(K value 0.61, 95 % CI 0.47–0.74). Sensitivity for infre-
quent episodic TTH (iTTH, ICHD-II code 2.1), frequent
episodic TTH (fTTH, ICHD-II code 2.2), and pTTH
(ICHD-II code 2.4) was 100 %; sensitivity for chronic
TTH (cTTH, ICHD-II code 2.3) was 66.6 % (95 % CI
54–80). Specificity was 100 %, except for iTTH (93.7 %,
95 % CI 86–100) [10]. Subjects with only one headache
attack in the last year were included in the iTTH group if
they had had at least ten lifetime episodes.
Statistics
Crude prevalence was the number of cases every 100
inhabitants. Crude prevalence was standardized by sex and
age in Parma’s general population aged 18 or over
according to the 2006 census [8]. We used the Chi-square
test for frequencies’ difference and Student’s t test for
means comparison. The 95 % CIs for prevalence were
calculated using the method suggested by Schoenberg [12].
Statistical analyses were performed using the Statistical
Package for the Social Sciences (SPSS), version 17.0 for
Windows.
Table 1 Gender and age distribution of Parma’s general population of the initial sample and of responders
Age (years) Parma’s general populationa Initial sampleb Respondersc
F M Total F M Total F M Total
n % n % n % n % n % n % n % n % n %
18–29 10,253 12.7 10,582 14.9 20,835 13.7 82 12.1 69 11.7 151 11.9 51 10.0 33 8.3 84 9.3
30–39 15,105 18.7 15,208 21.3 30,313 19.9 86 12.6 93 15.8 179 14.1 55 10.8 51 12.9 106 11.7
40–49 13,834 17.1 13,845 19.4 27,679 18.2 98 14.4 104 17.7 202 15.9 78 15.4 61 15.4 139 15.4
50–59 11,738 14.5 10,628 14.9 22,366 14.7 106 15.6 98 16.6 204 16.1 96 18.9 74 18.7 170 18.8
60–69 11,505 14.2 9,925 13.9 21,430 14.1 103 15.1 103 17.5 206 16.2 86 16.9 88 22.2 174 19.2
70–79 10,059 12.4 7,239 10.2 17,298 11.4 107 15.7 81 13.8 188 14.8 93 18.3 64 16.2 157 17.4
[79 8,366 10.4 3,853 5.4 12,219 8.0 99 14.5 41 6.9 140 11.0 49 9.6 25 6.3 74 8.2
Total 80,860 53.1 71,280 46.9 152,140 681 53.6 589 46.4 1,270 508 56.2 396 43.8 904
a Parma’s general population as of 31 December 2006 (www.statistica.comune.parma.it)
b Patients registered in the lists of one general practitioner
c Subjects that completed the questionnaire
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Ethics
The study was approved by the University of Parma Ethics
Board on 13 February 2007. All subjects gave their
informed consent.
Results
Responders and representativeness
The 904 responders (71.2 % of the initial study sample)
included 508 women (56.2 %; mean age 55.9 years, SD
17.2 years, max. 92 years) and 396 men (43.8 %; mean age
55.0 years, SD 18.2 years, max. 91 years). In 89 cases (48
men and 41 women), the interview was conducted by
phone. No statistically significant differences were found in
gender and age distribution between Parma’s general
population, the initial study sample and responders. The
only exception was the 18-to-29-year age group, which
showed a difference between responders and the general
population (p = 0.046) (Table 1).
Non-responders
366 subjects (173 women, 47.3 %, and 193 men, 52.7 %)
could not be recruited for the study due to reasons reported
in Fig. 1. There were significantly fewer women than men
(p = 0.005), especially in the 40–49 (p = 0.002) and
50–59 (p = 0.007) age groups. Mean age was 55.5 years
(SD 17.8 years, max. 92 years) for responders and
51.9 years (SD 17.6 years, max. 89 years) for non-
responders (p = 0.001).
Crude prevalence
Crude prevalence rates by gender and age for dTTH, iTTH,
fTTH and cTTH are reported in Table 2A–D.
A total of 175 subjects (19.4 %, 95 % CI 16.8–21.9) had
a diagnosis of dTTH: 102 were women (20.1 %, 95 % CI
16.6–23.6) and 73 were men (18.4 %, 95 % CI 14.6–22.3)
with an F:M ratio of 1.1:1 (Fig. 2a). Age distribution
showed a stable prevalence until age 70, followed by a
decreasing trend in the next life decades; in women this
decrease in prevalence seemed to occur earlier than in men,
beginning in the sixth decade (Table 2A). Eighty-one
subjects (9 %, 95 % CI 7.1–10.8) had iTTH, 45 of them
female (8.9 %, 95 % CI 6.4–11.3) and 36 male (9.1 %,
95 % CI 6.3–11.9; F:M ratio = 1:1; Fig. 2b); (b) 89 sub-
jects (9.8 %, 95 % CI 7.9–11.8) had fTTH, 54 of them
female (10.6 %, 95 % CI 7.9–13.3) and 35 male (8.8 %,
95 % CI 6–11.6; F:M ratio = 1.2:1; Fig. 2c); (c) for cTTH,
crude prevalence was 0.6 %, 95 % CI 0.1–1 (0.6 %, 95 %
CI 0–1.3 in women; 0.5 %, 95 % CI 0–1.2 in men; F:M
ratio = 1.2:1; Fig. 2d).
Crude prevalence by gender and age for pTTH is
reported in Table 2E. Twenty-one subjects had pTTH
(2.3 %, 95 % CI 1.3–3.3), 13 of them female (2.6 %, 95 %
CI 1.2–3.9) and eight male (2 %, 95 % CI 0.6–3.4) with an
F:M ratio of 1.3:1 (Fig. 2e).
Adjusted prevalence
Adjusted prevalence for dTTH was 20.5 % (95 % CI
17.8–23.1), i.e., 19.4 % (95 % CI 15.5–23.3) in men and
21.2 % (95 % CI 17.6–24.8) in women. Of the patients
studied, 9.4 % (95 % CI 7.5–11.3) had iTTH (9.8 %, 95 %
CI 6.9–12.7 in men; 9.2 %, 95 % CI 6.7–11.7, in women),
10.6 % (95 % CI 8.6–12.6) had fTTH (9.3 %, 95 % CI
6.4–12.2 in men; 11.5 %, 95 % CI 8.7–14.2 in women),
and 0.6 % (95 % CI 0.1–1) had cTTH (0.6 %, 95 % CI
0–1.3 in men; 0.6 %, 95 % CI 0–1.2 in women). Adjusted
prevalence for pTTH was 2.4 %, 95 % CI 1.4–3.4 (2.2 %,
95 % CI 0.8–3.7 in men; 2.5 %, 95 % CI 1.1–3.8 in
women).
Discussion
The crude past-year prevalence of dTTH in Parma’s adult
general population was 19.4 %, without differences in sex
distribution. This is the first population-based study on
TTH past-year prevalence conducted in Italy on adult
subjects aged 18 or over since the publication of the IHS
diagnostic criteria in 1988 [6]; Italian data currently
available for the prevalence of this headache subtype
concern subjects aged 65 or over [7, 13]. Data on TTH
prevalence in adult populations are available from the
international literature. In Table 3, we report population-
based studies on past-year TTH prevalence conducted all
over the world since 1988 and their respective results [4, 5,
7, 13–33]. In European countries, the past-year prevalence
of dTTH ranges from 5.1 % in Eastern Europe [4] to
281 (22.1%) subjects unreachable (138 F, 143 M) 
28 (2.2%) subjects unable to participate (13 F, 15 M) 
27 (2.1%) subjects unwilling to participate (4 F, 23 M) 
15 (1.2%) subjects dead (10 F, 5 M) 
8 (0.6%) subjects absent (5 F, 3 M) 
7 (0.5%) subjects relocated (3 F, 4 M)
Initial study sample: 1,270 subjects 
Completed the interview: 904  subjects (815 face-to-face, 89 by phone)  
Eligible sample, non-participants (with respective reasons), and final sample.  
Fig. 1 Study population flow chart
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Table 2 Crude past-year prevalence of tension-type headache (TTH) by age and gender
Age (years) M F Total
n % 95 % CI n % 95 % CI n % 95 % CI
(A) Definite TTHa
18–29 11 33.3 17.2–49.4 11 21.6 10.3–32.9 22 26.2 16.8–35.6
30–39 8 15.7 5.7–25.7 16 29.1 17.1–41.1 24 22.6 14.7–30.6
40–49 14 23.0 12.4–33.5 21 26.9 17.1–36.8 35 25.2 18.0–32.4
50–59 12 16.2 7.8–24.6 24 25.0 16.3–33.7 36 21.2 15.0–27.3
60–69 20 22.7 14.0–31.5 15 17.4 9.4–25.5 35 20.1 14.2–26.1
70–79 7 10.9 3.3–18.6 11 11.8 5.3–18.4 18 11.5 6.5–16.4
[79 1 4.0 0–11.7 4 8.2 0.5–15.8 5 6.8 1.0–12.5
Total 73 18.4 14.6–22.3 102 20.1 16.6–23.6 175 19.4 16.8–21.9
(B) Infrequent episodic TTH
18–29 7 21.2 8–35.2 4 7.8 0.5–15.2 11 13.1 5.9–20.3
30–39 3 5.9 0–12.3 7 12.7 3.9–21.5 10 9.4 3.9–15.0
40–49 6 9.8 2.4–17.3 8 10.3 3.5–17.0 14 10.1 5.1–15.1
50–59 7 9.5 2.8–16.1 15 15.6 8.4–22.9 22 12.9 7.9–18.0
60–69 11 12.5 5.6–19.4 5 5.8 0.9–10.8 16 9.2 4.9–13.5
70–79 2 3.1 0–7.4 4 4.3 0.2–8.4 6 3.8 0.8–6.8
[79 – – – 2 4.1 0–9.6 2 2.7 0–6.4
Total 36 9.1 6.3–11.9 45 8.9 6.4–11.3 81 9.0 7.1–10.8
(C) Frequent episodic TTH
18–29 4 12.1 1.0–23.3 7 13.7 4.3–23.2 11 13.1 5.9–20.3
30–39 4 7.8 0.5–15.2 9 16.4 6.6–26.1 13 12.3 6.0–18.5
40–49 8 13.1 4.6–21.6 12 15.4 7.4–23.4 20 14.4 8.6–20.2
50–59 5 6.8 1.0–12.5 9 9.4 3.5–15.2 14 8.2 4.1–12.4
60–69 9 10.2 3.9–16.6 8 9.3 3.2–15.4 17 9.8 5.4–14.2
70–79 4 6.3 0.3–12.2 7 7.5 2.2–12.9 11 7.0 3.0–11.0
[79 1 4.0 0–11.7 2 4.1 0–9.6 3 4.1 0–8.5
Total 35 8.8 6.0–11.6 54 10.6 7.9–13.3 89 9.8 7.9–11.8
(D) Chronic TTH
18–29 – – – – – – – – –
30–39 1 2.0 0–5.8 – – – 1 0.9 0–2.8
40–49 – – – 1 1.3 0–3.8 1 0.7 0–2.1
50–59 – – – – – – – – –
60–69 – – – 2 2.3 0–5.5 2 1.1 0–2.7
70–79 1 1.6 0–4.6 – – – 1 0.6 0–1.9
[79 – – – – – – – – –
Total 2 0.5 0–1.2 3 0.6 0–1.3 5 0.6 0.1–1
(E) Probable TTH
18–29 – – – 2 3.9 0–9.2 2 2.4 0–5.6
30–39 2 3.9 0–9.2 – – – 2 1.9 0–4.5
40–49 2 3.3 0–7.7 4 5.1 0.2–10.0 6 4.3 0.9–7.7
50–59 3 4.1 0–8.5 5 5.2 0.8–9.7 8 4.7 1.5–7.9
60–69 – – – 2 2.3 0–5.5 2 1.1 0–2.7
70–79 1 1.6 0–4.6 – – – 1 0.6 0–1.9
[79 – – – – – – – – –
Total 8 2.0 0.6–3.4 13 2.6 1.2–3.9 21 2.3 1.3–3.3
a Definite TTH represents the sum of infrequent episodic TTH, frequent episodic TTH and chronic TTH
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74.0 % in Western Europe [5]. Our results are in agreement
with those of Vukovic´ et al. [19] who in Croatia found a
dTTH prevalence of 21.2 %, 23.2 % in women and 19.1 %
in men. Fewer records exist from other continents: seven
studies were conducted in Asia on the past-year prevalence
of dTTH [23–29], and only two in both South America [30,
31] and Africa [32, 33]. The prevalence estimate in our
study was slightly lower than the average in the Asian
studies, which ranges from 10.8 % in China [29] to 36.9 %
in Jordan [23]. Rates from the South American studies are
comparable with 11.9 % in Brazil [31] and 26.9 % in Chile
[30], while in the African studies they are lower than 10 %,
namely, 9.4 % in Ethiopia [32] and 5.4 % in Tanzania [33].
To date, only one record exists from the USA and it comes
from a study conducted in 1998 by Schwartz et al. [14],
which indicates a past-year dTTH prevalence of 40.5 %.
This figure is almost double that calculated in Parma;
however, the rates are not comparable because the inter-
view mode used in the US study is different from that of
the PACE study (telephonic vs. face-to-face interviews).
As regards TTH frequency in males and in females, in
several studies, including ours, there was no disparity
between genders [14, 22–24].
In our sample, the evaluation of past-year dTTH prev-
alence by age ranges shows a homogeneous distribution
until the sixth decade. This finding is in agreement with
most studies, which report a decrease in prevalence after
age 60 [5, 14, 17, 31] and after age 70 [28]. Unlike
migraine, whose prevalence decreases markedly after age
50 [34], TTH seems to last longer in the lives of those who
suffer from it.
The past-year prevalence of TTH in Parma’s adult
general population was 9.8 % for fTTH, 9 % for iTTH, and
0.6 % for cTTH without differences in sex distribution.
Data in the international literature on episodic subtypes
of TTH (iTTH and fTTH) are scarce. Data are entirely
conflicting for the past-year prevalence of iTTH; about
fTTH our results confirm Ayzenberg et al.’s [22] estimates
(Table 3). Chronic TTH is the most widely studied subtype
and it is less than 1 % prevalence rate that we found in this
study is confirmed by several authors [4, 16, 31, 33]. In our
sample, we found no gender differences in the distribution
of cTTH, while some studies report a higher prevalence of
cTTH in women than in men [14, 16, 18, 28, 30, 32].
The differences in the various sets of data existing on
past-year dTTH prevalence can be attributed to a variety of
reasons, including the variability of methodological
approaches and the differences among study populations,
which are mainly due to geographical, demographic, racial,
economic, and psychosocial factors. As extensively dis-
cussed in our previous article on migraine prevalence [34],
we believe that the reliability of our results may have been
favored by some methodological aspects of our study, in
particular: (a) the recruitment of the initial sample, more
than 70 % of which was sex and age matched to Parma’s
general population; (b) the general question that started our
interview (‘‘Have you had headache in the last year’’),
which compared to questions on specific clinical features
(such as severity) was more suitable for an early detection
of sufferers; (c) the procedure followed, i.e., a face-to-face
interview complete with neurological examination per-
formed by a headache expert; and (d) the detection of all
possible headache types reported by headache patients
through the analysis of the clinical features of each type.
In conclusion, data on the epidemiology of TTH are
highly variable. Our study results indicate a past-year
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dTTH prevalence at the lower limit of data ranges currently
available for Western countries. It should be noted, how-
ever, that no reliable comparison is possible, due to the
shortage of data currently available in the literature. We
believe that it is crucial to conduct studies with comparable
methodology to clarify the actual prevalence of this
headache type.
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